Smyth, Elizabeth Catherine; Peeters, Ellen; Knoedler, Maren Kristina et al.
EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/ or R1)-An open-label randomized controlled phase II study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Czauderna, Carolin; Poplawski, Alicia; O'Rourke, Colm J. et al.
Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesisJCI INSIGHT. Bd. 6. H. 17. 2021
Haeuser, Friederike; Sprinzl, Martin F.; Dreis, Kim J. et al.
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admissionMEDICAL MICROBIOLOGY AND IMMUNOLOGY. Bd. 210. H. 2-3. 2021 S. 165-171
Gerges, Christian; Neumann, ?; Ishaq, Sauid et al.
Evaluation of a novel colonoscope offering flexibility adjuster - a retrospective observational studyTHERAPEUTIC ADVANCES IN GASTROENTEROLOGY. Bd. 14. 2021
Neumann, Helmut; Kreft, Andreas; Sivanathan, Visvakanth et al.
Evaluation of novel LCI CAD EYE system for real time detection of colon polypsPLOS ONE. Bd. 16. H. 8. 2021
Deutschbein, Timo; Jaursch-Hancke, Cornelia; Knappe, Ulrich J. et al.
First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary TumorsEXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. Bd. 129. H. 3. 2021 S. 250-264
Moehler, Markus H.; Shitara, Kohei; Garrido, Marcelo et al.
First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649.JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Moehler, M.; Shitara, K.; Garrido, M. et al.
First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): expanded efficacy and safety data from CheckMate 649ONCOLOGY RESEARCH AND TREATMENT. Bd. 44. 2021 S. 79-80
Janjigian, Yelena Y.; Shitara, Kohei; Moehler, Markus et al.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trialLANCET. Bd. 398. H. 10294. 2021 S. 27-40
Moehler, M.; Valle, J. W.; Hollebecque, A. et al.
Foenix-CCA2 quality of life data for Futibatinib-treated intrahepatic cholangiocarcinoma (ICCA) patients with FGFR2 fusions/rearrangementsONCOLOGY RESEARCH AND TREATMENT. Bd. 44. 2021 S. 223-224